Literature DB >> 9504478

Neuroradiologic findings in Marinesco-Sjögren syndrome.

B A Georgy1, R D Snow, B G Brogdon, W Wertelecki.   

Abstract

PURPOSE: Our purpose was to determine the neuroradiologic findings of Marinesco-Sjögren syndrome on plain skull radiographs, CT, and MR images.
METHODS: Eight patients with proved Marinesco-Sjögren syndrome (age range, 4 to 56 years) had a total of nine CT scans, seven MR imaging studies, and two plain radiographic examinations of the skull. The findings were reviewed retrospectively, with particular attention to the size of the posterior fossa and cerebellum.
RESULTS: All patients had hypoplastic cerebellar hemispheres and a hypoplastic vermis in a small posterior fossa. One patient had a midline posterior fossa cyst and another had agenesis of the corpus callosum.
CONCLUSION: Hypoplasia of the cerebellar hemispheres and the vermis and a small posterior fossa are the most prominent neuroradiologic findings in Marinesco-Sjögren syndrome.

Entities:  

Mesh:

Year:  1998        PMID: 9504478      PMCID: PMC8338194     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  3 in total

Review 1.  BiP and its nucleotide exchange factors Grp170 and Sil1: mechanisms of action and biological functions.

Authors:  Julia Behnke; Matthias J Feige; Linda M Hendershot
Journal:  J Mol Biol       Date:  2015-02-16       Impact factor: 5.469

Review 2.  MR imaging features in Marinesco-Sjögren syndrome: severe cerebellar atrophy is not an obligatory finding.

Authors:  Anke Reinhold; Ianina Scheer; Rüdiger Lehmann; Luitgard M Neumann; Theodor Michael; Raymonda Varon; Arpad Von Moers
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

3.  Cognitive Impairment and Brain Imaging Characteristics of Patients with Congenital Cataracts, Facial Dysmorphism, Neuropathy Syndrome.

Authors:  Teodora Chamova; Dora Zlatareva; Margarita Raycheva; Stoyan Bichev; Luba Kalaydjieva; Ivailo Tournev
Journal:  Behav Neurol       Date:  2015-04-28       Impact factor: 3.342

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.